NASDAQ:MMED MiniMed Group (MMED) Stock Price, News & Analysis $17.45 -0.33 (-1.83%) As of 01:42 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About MiniMed Group Stock (NASDAQ:MMED) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MiniMed Group alerts:Sign Up Key Stats Today's Range$17.36▼$18.2450-Day Range$16.71▼$22.7652-Week Range$10.65▼$24.43Volume1.64 million shsAverage Volume3.64 million shsMarket Capitalization$4.91 billionP/E RatioN/ADividend YieldN/APrice Target$24.13Consensus RatingModerate Buy Company Overview MiniMed Group focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery. The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care. MiniMed’s operations trace to Medtronic’s diabetes business, which developed and marketed diabetes-management products internationally. MiniMed products and services have been offered in multiple markets, though availability varies by location.AI Generated. May Contain Errors. Read More MiniMed Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks68th Percentile Overall ScoreMMED MarketRank™: 3.40281465746 of 5 starsMiniMed Group scored higher than 68% of companies evaluated by MarketBeat, and ranked 231st out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingMiniMed Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.68, and is based on no strong buy ratings, 14 buy ratings, 4 hold ratings, and 1 sell rating.Upside PotentialMiniMed Group has a consensus price target of $24.13, representing about 37.4% upside from its current price of $17.56.Amount of Analyst CoverageMiniMed Group has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about MiniMed Group's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-13.89% Earnings GrowthEarnings for MiniMed Group are expected to decrease by -13.89% in the coming year, from $0.72 to $0.62 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MiniMed Group is -25.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MiniMed Group is -25.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMiniMed Group has a P/B Ratio of 1.37. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.49% of the float of MiniMed Group has been sold short.Short Interest Ratio / Days to CoverMiniMed Group has a short interest ratio ("days to cover") of 0.96, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MiniMed Group has recently decreased by 52.80%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMiniMed Group does not currently pay a dividend.Dividend GrowthMiniMed Group does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.74 News SentimentMiniMed Group has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for MiniMed Group this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 3 people have added MiniMed Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MiniMed Group insiders have not sold or bought any company stock.Percentage Held by Insiders0.02% of the stock of MiniMed Group is held by insiders.Percentage Held by InstitutionsMiniMed Group has minimal institutional ownership at this time.Read more about MiniMed Group's insider trading history. Receive MMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MiniMed Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MMED Stock News HeadlinesMiniMed: The Split-Off Hangover Is Hiding A Full-Stack Product Cycle1 hour ago | seekingalpha.comMiniMed Group: An Improving PropositionNovember 17 at 9:35 AM | seekingalpha.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 18 at 1:00 AM | Profits Run (Ad)MiniMed Launches MiniMed Flex™, its Smallest and Most Discrete Insulin Pump, in EuropeNovember 17 at 7:56 AM | prnewswire.comFDA Clears MiniMed Fit™ -- World's First and Only Tubeless Insulin Pump with Up to Seven-Day Wear and Zero InterruptionsNovember 16 at 9:05 AM | prnewswire.comMiniMed Group Inc (MMED) - What Are Analysts Saying About This Stock?November 16 at 1:33 AM | americanbankingnews.comMiniMed Group, Inc. (MMED)November 5, 2026 | finance.yahoo.comMiniMed to Participate in Upcoming Investor ConferencesNovember 5, 2026 | prnewswire.comSee More Headlines MMED Stock Analysis - Frequently Asked Questions How have MMED shares performed this year? MiniMed Group's stock was trading at $18.00 on March 9, 2026. Since then, MMED shares have decreased by 2.5% and is now trading at $17.5550. How were MiniMed Group's earnings last quarter? MiniMed Group Inc (NASDAQ:MMED) released its earnings results on Wednesday, June, 3rd. The company reported ($0.68) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.46. The company's quarterly revenue was up 15.6% compared to the same quarter last year. Read the conference call transcript. When did MiniMed Group IPO? MiniMed Group (MMED) raised $742 million in an initial public offering (IPO) on Thursday, March 5th 2026. The company issued 28,000,000 shares at a price of $25.00-$28.00 per share. Who are MiniMed Group's major shareholders? MiniMed Group's top institutional shareholders include Healthcare of Ontario Pension Plan Trust Fund (0.61%), Boston Partners (0.32%), First Trust Advisors LP (0.29%) and State Street Corp (0.25%). How do I buy shares of MiniMed Group? Shares of MMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/18/20269th Annual Evercore ISI HealthCONx Conference12/01/2026Citi Annual Global Healthcare Conference 202612/02/202638th Annual Healthcare Conference12/03/2026Fiscal Year End4/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:MMED CIK2062583 Webwww.minimed.com Phone(763) 222-9423FaxN/AEmployees2,800Year FoundedN/APrice Target and Rating Average Price Target for MiniMed Group$24.13 High Price Target$30.00 Low Price Target$16.00 Potential Upside/Downside+38.3%Consensus RatingModerate Buy Rating Score (0-4)2.68 Research Coverage19 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E Ratio28.15 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.81 Quick Ratio1.36 Sales & Book Value Annual Sales$3.10 billion Price / Sales1.58 Cash FlowN/A Price / Cash FlowN/A Book Value$12.86 per share Price / Book1.36Miscellaneous Outstanding Shares281,350,000Free Float281,294,000Market Cap$4.91 billion OptionableOptionable BetaN/A The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:MMED) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiniMed Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share MiniMed Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.